[HTML][HTML] Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer
K Kanda, K Fujimoto, R Mochizuki, K Ishida, B Lee - BMC cancer, 2019 - Springer
Background Appropriate assessment is essential for the management of chemotherapy-
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
[HTML][HTML] Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer
K Kanda, K Fujimoto, R Mochizuki, K Ishida, B Lee - BMC Cancer, 2019 - ncbi.nlm.nih.gov
Background Appropriate assessment is essential for the management of chemotherapy-
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
[PDF][PDF] Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer
K Kanda, K Fujimoto, R Mochizuki, K Ishida, B Lee - 2019 - academia.edu
Background: Appropriate assessment is essential for the management of chemotherapy-
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer
K Kanda, K Fujimoto, R Mochizuki, K Ishida, B Lee - BMC Cancer, 2019 - go.gale.com
Background Appropriate assessment is essential for the management of chemotherapy-
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer
K Kanda, K Fujimoto, R Mochizuki, K Ishida… - BMC Cancer, 2019 - search.proquest.com
Background Appropriate assessment is essential for the management of chemotherapy-
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
[PDF][PDF] Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer
K Kanda, K Fujimoto, R Mochizuki, K Ishida, B Lee - 2019 - researchmap.jp
Background: Appropriate assessment is essential for the management of chemotherapy-
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
[HTML][HTML] Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer
K Kanda, K Fujimoto, R Mochizuki… - BMC …, 2019 - bmccancer.biomedcentral.com
Appropriate assessment is essential for the management of chemotherapy-induced
peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated, which is …
peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated, which is …
Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer.
K Kanda, K Fujimoto, R Mochizuki, K Ishida, B Lee - BMC Cancer, 2019 - europepmc.org
BACKGROUND: Appropriate assessment is essential for the management of chemotherapy-
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer
K Kanda, K Fujimoto, R Mochizuki, K Ishida, B Lee - BMC Cancer, 2019 - infona.pl
Background Appropriate assessment is essential for the management of chemotherapy-
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer
K Kanda, K Fujimoto, R Mochizuki, K Ishida… - BMC …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Appropriate assessment is essential for the management of chemotherapy-
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …
induced peripheral neuropathy (CIPN), an intractable symptom that cannot yet be palliated …